Spravato 28 mg/.2mL
Esketamine Hydrochloride · SOLUTION · Janssen Pharmaceuticals Inc.
Spravato is a nasal spray containing esketamine, a medication used to treat treatment-resistant depression in adults. It is administered under medical supervision in a healthcare setting.
Key Facts
- Brand Name
- Spravato
- Generic Name
- Esketamine Hydrochloride
- NDC Code (Product)
50458-028- Manufacturer
- Janssen Pharmaceuticals Inc.
- Strength
- 28 mg/.2mL
- Dosage Form
- SOLUTION
- Route
- NASAL
- Marketing Status
- DEA Schedule
- Schedule III (Controlled)
- Application #
- NDA211243
- Marketing Start
- 03/05/2019
Recall History
No Recall HistoryFrequently Asked Questions
What is Spravato used for?
Spravato is a nasal spray containing esketamine, a medication used to treat treatment-resistant depression in adults. It is administered under medical supervision in a healthcare setting.
Is Spravato a controlled substance?
Yes, Spravato is classified as CIII under the DEA Controlled Substances Act.
What is the generic name for Spravato?
The generic name for Spravato is Esketamine Hydrochloride. There are no other listed brand versions of Esketamine Hydrochloride.
What is the NDC code for Spravato 28 mg/.2mL?
The NDC (National Drug Code) for Spravato 28 mg/.2mL is 50458-028, listed by Janssen Pharmaceuticals Inc..
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)